Conformationally rigid aryl prostaglandins for use in glaucoma therapy
US6169111A · kind A · utility
15Cited by
11References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 1999 |
| Grant date | Jan 2, 2001 |
| Priority date | — |
| Expiry date | May 12, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Conformationally rigid aryl prostaglandins are useful in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic pharmaceutical compositions comprising said prostaglandins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.